| Financial Year |
March 31 2023 |
| Monetary Funds |
857,146,711.54 |
| Held-for-trading Financial Assets |
15,078,231.52 |
| Notes Receivable |
410,812,500.00 |
| Accounts Receivable |
103,992,357.65 |
| Advances to Suppliers |
36,211,373.45 |
| Other Receivables |
122,658,135.92 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,157,252,306.61 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
595,082,420.47 |
| Total Current Assets |
3,308,062,568.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,682,165,452.02 |
| Investment Properties |
101,726,004.96 |
| Fixed Assetes |
2,758,108,109.52 |
| Under-construction Projects |
483,493,853.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
411,911.22 |
| R&D expenses |
-- |
| Goodwill |
1,479,662.10 |
| Long-Term Deferred and Prepaid Expenses |
20,823,903.89 |
| Deferred Income Tax Assets |
76,914,855.48 |
| Other Non-Current Assets |
200,010,254.95 |
| Sub-Total of Non-Current Assets |
5,354,325,053.14 |
| Total Assets |
8,662,387,621.27 |
| Short-Term Loans |
735,914,579.18 |
| Trading Financial liabilities |
-- |
| Notes Payable |
469,000,513.92 |
| Accounts Payable |
359,659,271.58 |
| Accounts Received In Advance |
159,627,551.47 |
| Employee Compensation Payable |
32,857,649.20 |
| Taxes Payable |
96,264,636.77 |
| Interest Payable |
2,413,512.85 |
| Dividend Payable |
-- |
| Other payables |
653,729,274.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
79,810,005.27 |
| Sub-Total of Current Liabilities |
2,794,179,079.81 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
64,498,465.93 |
| Deferred Income Tax Liabilities |
1,721,350.44 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
66,219,816.37 |
| Total Liabilities |
2,860,398,896.18 |
| Paid-In Capital(Or Share Stock) |
2,212,887,079.00 |
| Capital Surplus |
3,255,981,589.76 |
| Surplus Reserve |
86,568,747.18 |
| LESS:Treasury Stock |
33,092,400.00 |
| Undistributed Profits |
468,640,667.23 |
| Minority Stockholder's Interest |
-199,940,483.98 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,001,929,209.07 |
| Owner's Equity（Stockholder's Equity） |
5,801,988,725.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,662,387,621.27 |
